01/29/2026 | Press release | Distributed by Public on 01/29/2026 08:57
Item 8.01 Other Events
Pursuant to a joint written consent dated January 22, 2026, of the Registrant's Board of Directors and stockholders constituting a majority of the voting power adopted certain resolutions to, among other matters, change the name of the Registrant to AVM Biotechnology, Inc. (the "Name Change"). Prior to implementing the Name Change, a Company -Related Action will be submitted to FINRA for review.
Section 9-Financial statements and Exhibits